Regional distribution of iron and iron‐regulatory proteins in the brain in aging and Alzheimer's disease
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
It is well established that iron, which is of considerable importance for normal neurological function, is highly regulated in all organ systems. However, until recently, iron regulation in the nervous system has received little attention. This study quantitatively compares the levels of the major iron‐regulatory proteins, transferrin and ferritin, and iron itself in three cerebral cortical regions of the human brain from material collected at autopsy. Three groups were studied: (1) normal adult (under 65 yr of age), (2) aged (> 65), and (3) Alzheimer's disease. Normally, transferrin is more abundant in white matter than in gray matter. Ferritin is approximately 10 x more abundant than transferrin throughout the brain regions examined and is evenly distributed, as is iron, in the gray and white matter. In Alzheimer's disease transferrin is consistently decreased particularly in the white matter of the various cerebral cortical regions examined whereas the iron and ferritin changes are inconsistent. The observations In this study are consistent with our general hypothesis that iron homeostasis is disrupted in the aging brain and the alterations in iron‐regulatory proteins are exacerbated in Alzheimer's disease. The decrease in transferrin levels could indicate a decreased mobility and subsequent utilization of iron in the brain. Such a decrease in iron availability could play a significant role in neuronal degeneration and increased peroxidative damage known to occur in Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ROSs are of course strongly implicated as partial contributors to the aging process (e.g. [31,43,980,1163,1182-1206]).”
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427 · cited 5×
“, 1990) and iron (Hill and Switzer, 1984; Hallgren and Sourander, 1958) have been reported.”
BackgroundResultInfluentialA white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
Brun, A., & Englund, E. (1986) · Annals of Neurology · doi:10.1002/ana.410190306 · Cited by 1,014 · cited 1×
“Although AD has been considered primarily a neurodegenerative (gray matter) disease, recent studies including those using brain imaging techniques have shown that white matter changes in AD are more common than previously reported (Wallin et al., 1989; Brun and Englund, 1986; Englund et al., 1988; Miller et al., 1980).”
BackgroundThe regional distribution and cellular localization of iron in the rat brain
Hill, J. M., & Switzer, R. C. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90046-0 · Cited by 486
Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains
Connor, J. R., Menzies, S. L., Martin, S. M. S., & Mufson, E. J. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270421 · Cited by 472
Self-citationA histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains
Connor, J. R., Menzies, S. L., St. Martin, S. M., & Mufson, E. J. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310111 · Cited by 467
Self-citationMILLER, A. K. H., ALSTON, R. L., & CORSELLIS, J. A. N. (1980) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1980.tb00283.x · Cited by 347
GOODMAN, L. (1953) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-195308000-00001 · Cited by 286 · cited 3×
“A disruption in brain iron metabolism has been suggested for a number of neurological diseases, including Alzheimer’s disease (Goodman, 1953).”
BackgroundResultInfluential
Cited by
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
“In the brains of patients with AD, iron accumulation occurs without the normal age-related increase in ferriti”
BackgroundSelf-citationIron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355
Imaging iron stores in the brain using magnetic resonance imaging
Haacke, E. M., Cheng, N. Y. C., House, M. J., Liu, Q., Neelavalli, J., Ogg, R. J., Khan, A., Ayaz, M., Kirsch, W., & Obenaus, A. (2005) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2004.10.001 · Cited by 995
Oxidative Alterations in Alzheimer's Disease
Markesbery, W. R., & Carney, J. M. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00215.x · Cited by 784
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome
Zhou, B., Westaway, S. K., Levinson, B., Johnson, M. A., Gitschier, J., & Hayflick, S. J. (2001) · Nature Genetics · doi:10.1038/ng572 · Cited by 752
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620
“…seen in such diverse neurodegenerative disorders as multiple system atrophy, Huntington’s disease, Alzheimer’s disease, progressive supranuclear palsy, aceruloplasminemia, and Hallervorden-Spatz (Dexter et al., 1991; Connor et al., 1992; Smith et al., 1997; Gitlin, 1998; Janetzky et al., 1997).”
The redox chemistry of the Alzheimer's disease amyloid β peptide
Smith, D. G., Cappai, R., & Barnham, K. J. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.002 · Cited by 608
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Belaidi, A. A., & Bush, A. I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 578
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Sayre, L. M., Perry, G., Harris, P. L. R., Liu, Y., Schubert, K. A., & Smith, M. A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740270.x · Cited by 540
Oxidative stress: Free radical production in neural degeneration
Götz, M. E., Künig, G., Riederer, P., & Youdim, M. B. H. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90055-8 · Cited by 482
Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration
Masaldan, S., Bush, A. I., Devos, D., Rolland, A. S., & Moreau, C. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.033 · Cited by 481
“Iron accumulates in the AD brain and is associated with senile plaques and NFTs (Goodman, 1953, Smith et al., 1997, Smith et al., 2007, Lovell et al., 1998, Connor et al., 1992).”
InfluentialA histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains
Connor, J. R., Menzies, S. L., St. Martin, S. M., & Mufson, E. J. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310111 · Cited by 467
Self-citationMasaldan, S., Clatworthy, S. A. S., Gamell, C., Meggyesy, P. M., Rigopoulos, A.-T., Haupt, S., Haupt, Y., Denoyer, D., Adlard, P. A., Bush, A. I., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2017.08.015 · Cited by 452
A delicate balance: Iron metabolism and diseases of the brain
Hare, D., Ayton, S., Bush, A., & Lei, P. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00034 · Cited by 443
“Both IRP1 and IRP2 are present in the rat (Siddappa et al., 2003) and human brain (Connor et al., 1992c); IRP1 has been suggested as the primary regulatory protein in the human brain and is capable of forming a double IRP1/IRE complex (Hu and Connor, 1996).”
BackgroundInfluentialOxidative damage in neurodegenerative disease
Jenner, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92347-7 · Cited by 418
Smith, M. A., Zhu, X., Tabaton, M., Liu, G., McKeel, D. W., Cohen, M. L., Wang, X., Siedlak, S. L., Dwyer, B. E., Hayashi, T., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1239 · Cited by 401
“disturbances in iron regulation in AD [52–56], mito-”
Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis
Altamura, S., & Muckenthaler, M. U. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1010 · Cited by 369
Alzheimer's disease, metal ions and metal homeostatic therapy
Zatta, P., Drago, D., Bolognin, S., & Sensi, S. L. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.002 · Cited by 369
The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer’s disease
Miranda, S., Opazo, C., Larrondo, L. F., Muñoz, F. J., Ruiz, F., Leighton, F., & Inestrosa, N. C. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00015-0 · Cited by 369
Metals and amyloid‐β in Alzheimer's disease
Maynard, C. J., Bush, A. I., Masters, C. L., Cappai, R., & Li, Q. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00434.x · Cited by 353
“…elevations in A -precipitating metal ions Fe levels in the brain have been shown by several groups to rise markedlywith age in both humans andmice (Drayer et al. 1986; Connor et al. 1992; Thomas et al. 1993; Bartzokis et al. 1997; Martin et al. 1998; Zecca et al. 2001; Maynard et al. 2002).”
BackgroundMaynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., White, A. R., Beyreuther, K., Masters, C. L., Bush, A. I., & Li, Q.-X. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204379200 · Cited by 353
Metallostasis in Alzheimer's disease
Ayton, S., Lei, P., & Bush, A. I. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.558 · Cited by 352
“This initial finding has later confirmed by multiple techniques [57, 184-188].”
ResultThe relevance of iron in the pathogenesis of Parkinson’s disease
Sian‐Hülsmann, J., Mandel, S., Youdim, M. B. H., & Riederer, P. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07132.x · Cited by 352
Beard, J. L., Connor, J. R., & Jones, B. C. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1993.tb03096.x · Cited by 333
Self-citationPatel, B. N., & David, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20185 · Cited by 327
Iron in Chronic Brain Disorders: Imaging and Neurotherapeutic Implications
Stankiewicz, J., Panter, S. S., Neema, M., Arora, A., Batt, C. E., & Bakshi, R. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.05.006 · Cited by 301
Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease
Albers, D. S., & Flint Beal, M. (2000) · Advances in Dementia Research · doi:10.1007/978-3-7091-6781-6_16 · Cited by 297
Burdo, J. R., Menzies, S. L., Simpson, I. A., Garrick, L. M., Garrick, M. D., Dolan, K. G., Haile, D. J., Beard, J. L., & Connor, J. R. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1256 · Cited by 297
“…are abnormal, including Parkinson disease (Earle, 1968; Sofic et al., 1988; Dexter et al., 1989; Dexter et al., 1991) Alzheimer disease (Connor et al., 1992a,b; Loeffler et al., 1995; Smith et al., 1998), Restless Legs Syndrome (RLS) (Earley et al., 2000), Huntington chorea (Bartzokis…”
BackgroundSelf-citationMandel, S., Amit, T., Reznichenko, L., Weinreb, O., & Youdim, M. B. H. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500156 · Cited by 291
Brain iron uptake and homeostatic mechanisms: An overview
Burdo, J. R., & Connor, J. R. (2003) · Biometals · doi:10.1023/a:1020718718550 · Cited by 290
“The increase in onset of AD accompanying an Hfe mutation is consistent with the reported role of iron in AD (Connor et al. 1992a; Connor et al. 1992b ).”
BackgroundResultInfluentialSelf-citationAtamna, H., & Boyle, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600134103 · Cited by 290
Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics
Duce, J. A., & Bush, A. I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.003 · Cited by 283
Ribosomal RNA in Alzheimer Disease Is Oxidized by Bound Redox-active Iron
Honda, K., Smith, M. A., Zhu, X., Baus, D., Merrick, W. C., Tartakoff, A. M., Hattier, T., Harris, P. L., Siedlak, S. L., Fujioka, H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500526200 · Cited by 280
Iron and Alzheimer’s Disease: An Update on Emerging Mechanisms
Lane, D. J. R., Ayton, S., & Bush, A. I. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179944 · Cited by 276
Transport of Iron in the Blood‐Brain‐Cerebrospinal Fluid System
Bradbury, M. W. B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020443.x · Cited by 270
The role of metallobiology and amyloid-β peptides in Alzheimer's disease
Roberts, B. R., Ryan, T. M., Bush, A. I., Masters, C. L., & Duce, J. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07500.x · Cited by 266
Vitamin E and Alzheimer disease: the basis for additional clinical trials
Grundman, M. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.630s · Cited by 264
Schrag, M., Mueller, C., Oyoyo, U., Smith, M. A., & Kirsch, W. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.001 · Cited by 263
Brain iron metabolism and its perturbation in neurological diseases
Crichton, R. R., Dexter, D. T., & Ward, R. J. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0470-z · Cited by 248
“…with centres of memory and thought processing which are lost in the clinical development of AD, notably the hippocampus and the cerebral cortex (Honda et al. 2005; Sipe et al. 2002), with iron accumulating more rapidly than ferritin in areas of particular neurodegeneration Connor et al. 1992).”
BackgroundNew Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity
Yoshiike, Y., Tanemura, K., Murayama, O., Akagi, T., Murayama, M., Sato, S., Sun, X., Tanaka, N., & Takashima, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010706200 · Cited by 244
Erikson, K. M., Pinero, D. J., Connor, J. R., & Beard, J. L. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.10.2030 · Cited by 237
“…stored in the brain primarily as ferritin, whereaswhether these changes in iron metabolism are due to altered transferrin is responsible for transporting iron in cerebral spinalacquisition or slow turnover rate of brain iron (Dallman and fluid and in plasma (Connor et al. 1992, Octave et al. 1983).”
Self-citationBrain iron metabolism: Neurobiology and neurochemistry
Ke, Y., & Qian, Z. M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.07.009 · Cited by 236
“Changes in iron metabolism with age are well known (Connor et al., 1992; Martin et al., 1998; Bartzokis, 2004; Cass et al., 2007).”
BackgroundIncreased regional brain concentrations of ceruloplasmin in neurodegenerative disorders
Loeffler, D. A., LeWitt, P. A., Juneau, P. L., Sima, A. A. F., Nguyen, H.-U., DeMaggio, A. J., Brickman, C. M., Brewer, G. J., Dick, R. D., Troyer, M. D., et al. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00782-2 · Cited by 236
In Vivo Evaluation of Brain Iron in Alzheimer Disease Using Magnetic Resonance Imaging
Bartzokis, G., Sultzer, D., Cummings, J., Holt, L. E., Hance, D. B., Henderson, V. W., & Mintz, J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.47 · Cited by 235
“riety of neurodegenerative disorders, and iron involvement in the process of oxidative damage has been suggested as a common mechanism.(15,50,52,80-86) In addition to AD, the involvement of iron and free-radical neurotoxic processes has been postulated for a variety of agerelated neuropsychiatric disorders, such as Pa…”
Qian, Z. M., & Wang, Q. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00012-5 · Cited by 230
Role of Iron in Neurodegenerative Disorders
Berg, D., & Youdim, M. B. H. (2006) · Topics in Magnetic Resonance Imaging · doi:10.1097/01.rmr.0000245461.90406.ad · Cited by 226
Mandel, S. A., Amit, T., Weinreb, O., Reznichenko, L., & Youdim, M. B. H. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00060.x · Cited by 221
Oxidative stress and neurodegenerative disorders
Sun, A. Y., & Chen, Y.-M. (1998) · Journal of Biomedical Science · doi:10.1007/bf02255928 · Cited by 215
Wang, Y., Wu, S., Li, Q., Sun, H., & Wang, H. (2023) · Advanced Science · doi:10.1002/advs.202300325 · Cited by 211
Ogg, R. J., Langston, J. W., Haacke, E. M., Steen, R. G., & Taylor, J. S. (1999) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(99)00017-x · Cited by 205
Mitochondrial iron metabolism and its role in neurodegeneration
Horowitz, M. P., & Greenamyre, J. T. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100354 · Cited by 195
“There is evidence that iron accumulation in affected regions of the AD brain may outstrip the ability of Ft to safely sequester it, which would lead to pathologic ROS formation through Fenton chemistry [76].”
Iron toxicity in neurodegeneration
Núñez, M. T., Urrutia, P., Mena, N., Aguirre, P., Tapia, V., & Salazar, J. (2012) · BioMetals · doi:10.1007/s10534-012-9523-0 · Cited by 180
“…globally decreased in the brain of AD subjects and instead of being in its regular location in oligodendrocytes, it appears to be sequestered in SP (Connor et al. 1992); Tf receptor is highly expressed in the neocortex and hippocampus of AD brains but localized to capillary endothelium with only a…”
BackgroundIsoforms of ferritin have a specific cellular distribution in the brain
Connor, J. R., Boeshore, K. L., Benkovic, S. A., & Menzies, S. L. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490370405 · Cited by 179
Self-citationThe comparative biology of neuromelanin and lipofuscin in the human brain
Double, K. L., Dedov, V. N., Fedorow, H., Kettle, E., Halliday, G. M., Garner, B., & Brunk, U. T. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7581-9 · Cited by 179
Raha, A. A., Vaishnav, R. A., Friedland, R. P., Bomford, A., & Raha-Chowdhury, R. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-55 · Cited by 177
“It is not clear whether this represents increased deposition of iron and other transition metals [97] in the region of plaques or a more general increase as iron levels have not been found to be consistently increased in AD brains [98-100] compared to age-matched controls.”
ResultMeadowcroft, M. D., Connor, J. R., Smith, M. B., & Yang, Q. X. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21731 · Cited by 176
“Histological data from previous studies using postmortem human AD tissue (14,45,54,55) also support the notion that focal iron load in A plaques is the dominant cause for faster T2 and T*2 decay.”
ResultSelf-citationIron regulation in the brain: Histochemical, biochemical, and molecular considerations
Connor, J. R., & Benkovic, S. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320710 · Cited by 176
Self-citationIron and iron management proteins in neurobiology
Connor, J. R., Menzies, S. L., Burdo, J. R., & Boyer, P. J. (2001) · Pediatric Neurology · doi:10.1016/s0887-8994(01)00303-4 · Cited by 173
“[18] Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ.”
BackgroundSelf-citationRedox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications
Butterfield, D. A., Perluigi, M., Reed, T., Muharib, T., Hughes, C. P., Robinson, R. A. S., & Sultana, R. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4109 · Cited by 168
“Further, the iron transport protein TF functions were also reported to be disrupted in AD (108).”
Alzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 150
The relationship between excitotoxicity and oxidative stress in the central nervous system
Bondy, S. C., & LeBel, C. P. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90144-j · Cited by 165
Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders
Li, J., Jia, B., Cheng, Y., Song, Y., Li, Q., & Luo, C. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3999083 · Cited by 165
Ayton, S., Portbury, S., Kalinowski, P., Agarwal, P., Diouf, I., Schneider, J. A., Morris, M. C., & Bush, A. I. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12282 · Cited by 164
Functional roles of transferrin in the brain
Leitner, D. F., & Connor, J. R. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.10.016 · Cited by 163
“decrease in Tf levels in some brain regions may contribute to loss of iron mobility in the brain with aging and disease [12].”
Self-citationVariations in Dietary Iron Alter Brain Iron Metabolism in Developing Rats
Piñero, D. J., Li, N.-Q., Connor, J. R., & Beard, J. L. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.2.254 · Cited by 163
Self-citationAbnormal localization of iron regulatory protein in Alzheimer’s disease
Smith, M. A., Wehr, K., Harris, P. L. R., Siedlak, S. L., Connor, J. R., & Perry, G. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00002-x · Cited by 162
Self-citationMetals and Alzheimer’s Disease: How Far Have We Come in the Clinic?
Adlard, P. A., & Bush, A. I. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170662 · Cited by 156
Aluminium(III) as a promoter of cellular oxidation
Zatta, P., Kiss, T., Suwalsky, M., & Berthon, G. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00074-7 · Cited by 159
Ashraf, A., Clark, M., & So, P.-W. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00065 · Cited by 158
“Tim-2, a ferritin receptor (Han et al., 2011), aids in oligodendrocyte iron uptake while non-Tf bound iron is taken up via DMT1. in the basal ganglia including the putamen, globus pallidus, and substantia nigra (Hallgren and Sourander, 1958; Connor et al., 1990, 1992, 1995).”
BackgroundIron in the Brain: An Important Contributor in Normal and Diseased States
Piñero, D. J., & Connor, J. R. (2000) · The Neuroscientist · doi:10.1177/107385840000600607 · Cited by 131
Self-citationHomozygosity mapping of Hallervorden–Spatz syndrome to chromosome 20p12.3–p13
Taylor, T. D., Litt, M. J., Kramer, P., Pandolfo, M., Angelini, L., Nardocci, N., Davis, S., Pineda, M., Hattori, H., Flett, P. J., et al. (1996) · Nature Genetics · doi:10.1038/ng1296-479 · Cited by 153
Promotion of transition metal-induced reactive oxygen species formation by β-amyloid
Bondy, S. C., Guo-Ross, S. X., & Truong, A. T. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00461-2 · Cited by 139
Peters, D. G., Connor, J. R., & Meadowcroft, M. D. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.007 · Cited by 146
“Decreased Tf in AD can impair oligodendrocytes from properly transporting iron (Connor et al., 1992b) (Fig.”
BackgroundInfluentialSelf-citationThe history of iron in the brain
Koeppen, A. H. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00202-d · Cited by 155
Jefferies, W. A., Food, M. R., Gabathuler, R., Rothenberger, S., Yamada, T., Yasuhara, O., & McGeer, P. L. (1996) · Brain Research · doi:10.1016/0006-8993(95)01407-1 · Cited by 149
Iron, Neuroinflammation and Neurodegeneration
Ward, R. J., Dexter, D. T., & Crichton, R. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137267 · Cited by 148
“In early studies of three cerebral cortical regions of post mortem AD material, transferrin was consistently decreased in the white matter [69], while no significant alterations in iron and ferritin changes were detected.”
BackgroundTao, Y., Wang, Y., Rogers, J. T., & Wang, F. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140396 · Cited by 134
“For these reasons, iron overload in the brain was thought to potentially be a disease–associated characteristic of AD [14, 24–26].”
Studies on lipid peroxidation in the rat brain
Cini, M., Fariello, R. G., Bianchetti, A., & Moretti, A. (1994) · Neurochemical Research · doi:10.1007/bf00971576 · Cited by 146
“284 Cini, Fariello, Bianchetti, and Moretti Alzheimer's disease ( 19 ).”
Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease
Gleason, A. J., & Bush, A. I. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00954-y · Cited by 143
Iron and Mechanisms of Neurotoxicity
Salvador, G. A., Uranga, R. M., & Giusto, N. M. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/720658 · Cited by 123
“The vulnerability of the brain to abnormal iron regulation has been demonstrated by the relationship between the failure of ferroxidases, ceruloplasmin [19, 20], ferritin [18, 21, 22], and frataxin [23, 24], iron accumulation (IA), and the onset of neurodegenerative diseases.”
BackgroundBiometals and Their Therapeutic Implications in Alzheimer's Disease
Ayton, S., Lei, P., & Bush, A. I. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0312-z · Cited by 142
“[99–108].”
Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease
Kim, H.-G., Park, S., Rhee, H. Y., Lee, K. M., Ryu, C.-W., Rhee, S. J., Lee, S. Y., Wang, Y., & Jahng, G.-H. (2017) · NeuroImage: Clinical · doi:10.1016/j.nicl.2017.08.019 · Cited by 125
“The first involved the wellknown regions for rich iron contents of the brain, reported in two previous studies (Connor et al., 1992; Haacke et al., 2005).”
Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease
Leskovjan, A. C., Kretlow, A., Lanzirotti, A., Barrea, R., Vogt, S., & Miller, L. M. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.11.073 · Cited by 133
“Increased Fe in the brain has been consistently observed in AD and a number of studies suggest that brain Fe content is altered in AD (Bartzokis et al., 2000; Connor et al., 1992; Deibel et al., 1996).”
Pericapillary Haem-Rich Deposits: Evidence for Microhaemorrhages in Aging Human Cerebral Cortex
Cullen, K. M., Kócsi, Z., & Stone, J. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600155 · Cited by 137
“Capillary abnormalities are also present in AD and the non-demented aged (Buee et al, 1994; Received 16 January 2005; revised 6 April 2005; accepted 21 April 2005; published online 25 May 2005 Correspondence: Dr KM Cullen, Anatomy and Histology, Anderson Stuart Building, The University of Sydney, NSW 2006, Australia.”
BackgroundMethodResultInfluentialSelective cell death in neurodegeneration: Why are some neurons spared in vulnerable regions?
Double, K. L., Reyes, S., Werry, E. L., & Halliday, G. M. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.001 · Cited by 137
Walton, J. R. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-132204 · Cited by 123
“Iron levels that rise in AD brains do so without the usual age-related rise in ferritin [439], probably as a consequence of the IRP2 stabilization.”
BackgroundMetal imaging in neurodegenerative diseases
Bourassa, M. W., & Miller, L. M. (2012) · Metallomics · doi:10.1039/c2mt20052j · Cited by 121
Free radicals in Alzheimer’s disease
Retz, W., Gsell, W., Münch, G. W., Rösler, M., & Riederer, P. F. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_22 · Cited by 129
Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia
Xu, J., Church, S. J., Patassini, S., Begley, P., Waldvogel, H. J., Curtis, M. A., Faull, R. L. M., Unwin, R. D., & Cooper, G. J. S. (2017) · Metallomics · doi:10.1039/c7mt00074j · Cited by 111
“71 In the brain, Zn 2+ is co-localized with glutamate and modulates both excitatory and inhibitory neurotransmission.”
Leveugle, B., Faucheux, B. A., Bouras, C., Nillesse, N., Spik, G., Hirsch, É. C., Agid, Y., & Hof, P. R. (1996) · Acta Neuropathologica · doi:10.1007/s004010050468 · Cited by 125
Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
Xiang, Y., Song, X., & Long, D. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03660-8 · Cited by 125
Potential sources of increased iron in the substantia nigra of parkinsonian patients
Gerlach, M., Double, K. L., Youdim, M. B. H., & Riederer, P. F. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_21 · Cited by 122
“AD is characterised by a decrease in the iron mobilisation protein transferrin (Connor et al., 1992), in contrast, PD is characterised by a decrease in iron storage capacity.”
BackgroundResultBrain iron accumulation in aging and neurodegenerative disorders
Hagemeier, J., Geurts, J. J. G., & Zivadinov, R. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.128 · Cited by 121
Bongarzone, E. R., Pasquini, J. M., & Soto, E. F. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490410209 · Cited by 107
Characterization of biometal profiles in neurological disorders
Pfaender, S., & Grabrucker, A. M. (2014) · Metallomics · doi:10.1039/c4mt00008k · Cited by 117
Role of iron in brain development, aging, and neurodegenerative diseases
Gao, Q., Zhou, Y., Chen, Y., Hu, W., Jin, W., Zhou, C., Yuan, H., Li, J., Lin, Z., & Lin, W. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2472871 · Cited by 119
“With aging, brain iron deposition is associated with changes in iron regulatory proteins, including decreased transferrin [86], impaired ferritin autophagy [87], and brain-derived hepcidin overexpression [88].”
Mitochondrial iron metabolism and its role in diseases
Gao, J., Zhou, Q., Wu, D., & Chen, L. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.12.005 · Cited by 117
Gerlach, M., Double, K. L., Ben‐Shachar, D., Zecca, L., Youdim, M. B. H., & Riederer, P. F. (2003) · Neurotoxicity Research · doi:10.1007/bf03033371 · Cited by 116
“Increased regional brain iron has also been variously reported in trinucleotide repeat disorders, such as Huntington’s disease (Dexter et al., 1991; Bartzokis et al., 2000) and the dementia syndromes, including Alzheimer’s disease (Connor et al., 1992; Dexter et al., 1993; Markesbery, 1997; Smith et al., 1997) and in…”
Background
Metadata
- Authors
- Connor, J. R., Snyder, B. S., Beard, J. L., Fine, R. E., & Mufson, E. J.
- Affiliations
- Pennsylvania State University (US)
- Edith Nourse Rogers Memorial Veterans Hospital (US)
- Corresponding author
- Connor, J. R.
- ORCID
- Snyder, B. S.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 1992-02
- Volume
- 31
- Issue
- 2
- Pages
- 327-335
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2079887405
- Cited by
- 374
- References
- 46
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 9 · 2023: 13 · 2022: 11 · 2021: 15 · 2020: 14 · 2019: 16 · 2018: 15 · 2017: 12 · 2016: 12 · 2015: 6 · 2014: 11 · 2013: 14 · 2012: 11
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neuroscience Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- National Institutes of Health (5r01ag009063-03)
- National Institute on Aging (AG09063)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- brain iron, iron homeostasis, transferrin, ferritin, Alzheimer's disease, brain aging, cerebral cortex, white matter, gray matter, iron regulatory proteins, neurodegeneration, peroxidative damage
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Alzheimer Disease, Brain Chemistry, Female, Ferritins, Homeostasis, Humans, Iron, Male, Middle Aged, Transferrin, Blotting, Western
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.